Replies to post #117883 on Innovation Pharmaceuticals Inc (IPIX)

[iclight]

"I also find the spleen lesion disappeared in one ovarian patient at medium dosage hard to believe. But it actually happened. "

That's great but not really what I'm discussing.

The 750 cohort is done. It was started prior to the ASCO abstract which was submitted in Feb of this year. 6 months ago. If there was even a partial response (your tumor shrinkage) that would have been PRed instead of the SD ovarian patients.

[youssef]

Sox Leo mention to me and he told me he got some heat from the hospital from releasing this or , next week they should hear something from the fda for ph 3 b , everything ready for u of Bologna but the delay from them , k is going to ph 2 for sure and the next 6 months will be a lot of information , Leo will not Pursue sa legally , no time to waste and he will prove it with the science , he show some e mails and some information I can t share but very encouraging , his value for the company like big kahuna